Jackelyn Y Boyden

Dr. Jackelyn Y Boyden

Children's Hospital of Philadelphia, Philadelphia, Mississippi, USA
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2021 in Journal of Pain and Symptom Management
Verified
Journal Article
Open access
Jackelyn Y BoydenJackelyn Y Boyden
Jackelyn Y Boyden
DHDouglas L. Hill
Douglas L. Hill
RNRussell T. Nye
Russell T. Nye
KBKira Bona
Kira Bona
EJEmily E. Johnston
Emily E. Johnston
CFChris Feudtner
Chris Feudtner
Parents of patients with a serious illness experience psychological distress, which impacts parents’ wellbeing and, potentially, their ability to care for their children. Parent psychological distress may be influenced by children’s symptom burden and by families’ financial difficulty. This study examined the associations among parent psychological distress, parent-reported patient symptoms, and financial difficulty, seeking to determine the relative association of financial difficulty and of patient symptoms to parent psychological distress. Cross-sectional study of baseline data for 601 parents of 532 pediatric palliative care patients enrolled in a prospective cohort study conducted at seven US children’s hospitals. Data included self-reported parent psychological distress and parent report of child’s symptoms and family financial difficulty. We used ordinary least squares multiple regressions to examine the association between psychological distress and symptom score, between psychological distress and financial difficulty, and whether the degree of financial difficulty modified the relationship between psychological distress and symptom score. The majority of parents were moderately to severely distressed (52%) or severely distressed (17%) and experienced some degree of financial difficulty (65%). While children’s symptom scores and family financial difficulty together explained more of the variance in parental psychological distress than either variable alone, parental distress was associated more strongly, and to a larger degree, with financial difficulty than with symptom scores alone. Parent psychological distress was associated with parent-reported patient symptoms and financial difficulty. Future work should examine these relationships longitudinally, and whether interventions to improve symptom management and ameliorate financial difficulties improve parental outcomes.

20 December 2021 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
CFChris Feudtner
Chris Feudtner
RNRussell T. Nye
Russell T. Nye
Jackelyn Y BoydenJackelyn Y Boyden
Jackelyn Y Boyden
KSKatherine E. Schwartz
Katherine E. Schwartz
EKEmilie R. Korn
Emilie R. Korn
DHDouglas L. Hill
Douglas L. Hill
When an infant, a child, or an adolescent has a life-threatening condition (LTC), adverse collateral effects on the mental and physical well-being of parents and siblings have been observed.1-4 Qualitative studies have found that parents of seriously ill children reported negative effects in their own physical health, family life, marriage, social life, finances, education, and career.1,5 A qualitative metasynthesis observed that parents of children with LTCs often felt like they were on a “relentless rollercoaster of highs and lows” significantly impacting parents’ emotional well-being and familial relationships.2,p95 Quantitative studies have found self-reported lower resilience, greater symptoms of posttraumatic distress, greater emotional distress, higher levels of anxiety, more health problems, fewer healthy behaviors, more unhealthy behaviors, sleep disturbances, and lower quality of life among parents of children with LTCs.6-15 If their child is hospitalized, parents may experience high levels of distress both during and after the hospitalization.9,16-18 Research regarding siblings, with few exceptions,3,4 has focused on those whose sister or brother had cancer; these siblings may experience greater stress, depression, anxiety, problems with eating and sleeping, behavioral problems, lower quality of life, disruption of academic and social life, and poorer relationships with their parents.10,19-22

31 July 2020 in Journal of Pain and Symptom Management
Verified
Journal Article
Open access
Jackelyn Y BoydenJackelyn Y Boyden
Jackelyn Y Boyden
MEMary Ersek
Mary Ersek
JDJanet A. Deatrick
Janet A. Deatrick
KWKimberley Widger
Kimberley Widger
GLGwenn LaRagione
Gwenn LaRagione
CFChris Feudtner
Chris Feudtner
Children with life-shortening serious illnesses and medically-complex care needs are often cared for by their families at home. Little, however, is known about what aspects of pediatric palliative and hospice care in the home setting (PPHC@Home) families value the most. To explore how parents rate and prioritize domains of PPHC@Home as the first phase of a larger study that developed a parent-reported measure of experiences with PPHC@Home. Twenty domains of high-value PPHC@Home, derived from the National Consensus Project’s Guidelines for Quality Palliative Care, the literature, and a stakeholder panel, were evaluated. Using a discrete choice experiment, parents provided their ratings of the most and least valued PPHC@Home domains. We also explored potential differences in how subgroups of parents rated the domains. Forty-seven parents participated. Overall, highest-rated domains included Physical aspects of care: Symptom management, Psychological/emotional aspects of care for the child, and Care coordination. Lowest-rated domains included Spiritual and religious aspects of care and Cultural aspects of care. In exploratory analyses, parents who had other children rated the Psychological/emotional aspects of care for the sibling(s) domain significantly higher than parents who did not have other children (P = 0.02). Furthermore, bereaved parents rated the Caregiver support at the end of life domain significantly higher than parents who were currently caring for their child (P = 0.04). No other significant differences in domain ratings were observed. Knowing what parents value most about PPHC@Home provides the foundation for further exploration and conversation about priority areas for resource allocation and care improvement efforts.

1 January 2018 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
Jackelyn Y BoydenJackelyn Y Boyden
Jackelyn Y Boyden
MCMartha A.Q. Curley
Martha A.Q. Curley
JDJanet A. Deatrick
Janet A. Deatrick
MEMary Ersek
Mary Ersek

10 June 2014 in Journal of Aerosol Medicine and Pulmonary Drug Delivery
Verified
Journal Article
Closed access
Jackelyn Y BoydenJackelyn Y Boyden
Jackelyn Y Boyden
SCStephen Robert Connor
Stephen Robert Connor
LOLily Otolorin
Lily Otolorin
SNSteven D. Nathan
Steven D. Nathan
PFPerry G. Fine
Perry G. Fine
JMJ. Cameron Muir
J. Cameron Muir
Background: Dyspnea significantly impacts quality of life and is one of the most common symptoms in advanced illness. Systemically-administered opioids and benzodiazepines have been the most studied and utilized pharmacologic treatments for refractory dyspnea. Less attention has been given to the use of these medications and others when nebulized. This article presents a review of the literature on the use of nebulized medications for the treatment of dyspnea related to cancer, chronic obstructive pulmonary disease, cystic fibrosis, interstitial lung disease, or experimentally-induced dyspnea. Methods: A systematic review of peer-reviewed literature was conducted using Medline/PubMed, CINAHL, Cochrane, and Google Scholar. Results: Thirty-nine publications were included in this review, including 17 high-quality clinical research studies, as defined by the GRADE system. The evidence for nebulized morphine remains mixed, whereas a potential benefit was suggested for nebulized furosemide, hydromorphone, and fentanyl. No conclusions could be drawn as to which disease population derived greatest benefit from nebulized medications, or whether jet or ultrasonic nebulizers were more effective for the delivery of these medications. Conclusions: More research is needed to assess the characteristics of specific diseases and the combination of different nebulizers and medications that may yield the greatest benefit, and to assess the safety and efficacy of the chronic use of nebulized opioids and furosemide. Until larger, longer-term studies are completed, the use of nebulized medications to treat dyspnea should be assessed on a case-by-case basis and may be considered if the hoped-for benefits outweigh potential harm.

14 January 2021 in BMC Palliative Care
Verified
Journal Article
Open access
PDF file
Jackelyn Y BoydenJackelyn Y Boyden
Jackelyn Y Boyden
CFChris Feudtner
Chris Feudtner
JDJanet A. Deatrick
Janet A. Deatrick
KWKimberley Widger
Kimberley Widger
GLGwenn LaRagione
Gwenn LaRagione
MEMary Ersek
Mary Ersek
Background: Many children with serious illnesses are receiving palliative and end-of-life care from pediatric palliative and hospice care teams at home (PPHC@Home). Despite the growth in PPHC@Home, no standardized measures exist to evaluate whether PPHC@Home provided in the U.S. meets the needs and priorities of children and their families. Methods: We developed and conducted a preliminary evaluation of a family-reported measure of PPHC@Home experiences using a multi-method, multi-stakeholder approach. Our instrument development process consisted of four phases. Item identification and development (Phase 1) involved a comprehensive literature search of existing instruments, guidelines, standards of practice, and PPHC@Home outcome studies, as well as guidance from a PPHC stakeholder panel. Phase 2 involved the initial item prioiritization and reduction using a discrete choice experiment (DCE) with PPHC professionals and parent advocates. Phase 3 involved a second DCE with bereaved parents and parents currently receiving care for their child to further prioritize and winnow the items to a set of the most highly-valued items. Finally, we conducted cognitive interviews with parents to provide information about the content validity and clarity of the newly-developed instrument (Phase 4). Results: Items were compiled predominantly from three existing instruments. Phase 2 participants included 34 PPHC providers, researchers, and parent advocates; Phase 3 participants included 47 parents; and Phase 4 participants included 11 parents. At the completion of Phase 4, the Experiences of Palliative and Hospice Care for Children and Caregivers at Home (EXPERIENCE@Home) Measure contains 22 of the most highly-valued items for evaluating PPHC@Home. These items include “The care team treats my child’s physical symptoms so that my child has as good a quality of life as possible”, “I have regular access to on-call services from our care team”, and “The nurses have the knowledge, skills, and experience to support my child’s palliative or hospice care at home.” Conclusions: The EXPERIENCE@Home Measure is the first known to specifically measure family-reported experiences with PPHC@Home in the U.S. Future work will include formal psychometric evaluation with a larger sample of parents, as well as evaluation of the clinical utility of the instrument with PPHC@Home teams.